Ventana’s Promising New Anti-Obesity Patent - Market Wire
LONDON, UNITED KINGDOM–(Marketwire - July 28, 2009) - Ventana Biotech Inc (”Ventana”)(PINK SHEETS:VNTA), a biotechnology company that is developing a appetite-suppressing chewing gum, today released detailed information about its innovative Anti
Unproven Remedies: Tests show many supplements have quality problems - Journal Times
Lead in ginkgo pills. Arsenic in herbals. Bugs in a baby’s colic and teething syrup. Toxic metals and parasites are part of nature, and all of these have been found in “natural” products and dietary supplements in recent years. Set aside the
Ventana’s Promising New Anti-Obesity Patent - Market Wire
LONDON, UNITED KINGDOM–(Marketwire - July 28, 2009) - Ventana Biotech Inc (”Ventana”)(PINK SHEETS:VNTA), a biotechnology company that is developing a appetite-suppressing chewing gum, today released detailed information about its innovative Anti
Unproven Remedies: Tests show many supplements have quality problems - Journal Times
Lead in ginkgo pills. Arsenic in herbals. Bugs in a baby’s colic and teething syrup. Toxic metals and parasites are part of nature, and all of these have been found in “natural” products and dietary supplements in recent years. Set aside the
